{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:16:02Z","timestamp":1789992962017,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Liaoning Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024-MS-248"],"award-info":[{"award-number":["2024-MS-248"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.gene.2026.150360","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:12:50Z","timestamp":1787238770000},"page":"150360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Integrative multi-omics analysis identifies an enhancer-driven ELF3\u2013CLDN4 regulatory axis that shapes an immunosuppressive microenvironment and predicts prognosis in high-grade serous ovarian cancer"],"prefix":"10.1016","volume":"1012","author":[{"given":"Pingping","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1929-3878","authenticated-orcid":false,"given":"Zuofei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.gene.2026.150360_b0005","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1158\/1078-0432.CCR-18-3200","article-title":"Biological consequences of MHC-II expression by tumor cells in cancer","volume":"25","author":"Axelrod","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.gene.2026.150360_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2025.103069","article-title":"Editorial overview - new concepts in drug discovery (2025)","volume":"93","author":"Biggin","year":"2025","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"10","key":"10.1016\/j.gene.2026.150360_b0015","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41577-018-0044-0","article-title":"CD4(+) T cell help in cancer immunology and immunotherapy","volume":"18","author":"Borst","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"8072","key":"10.1016\/j.gene.2026.150360_b0020","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41586-025-09221-6","article-title":"Range extender mediates long-distance enhancer activity","volume":"643","author":"Bower","year":"2025","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.gene.2026.150360_b0025","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/s41592-023-01938-4","article-title":"SCENIC+: single-cell multiomic inference of enhancers and gene regulatory networks","volume":"20","author":"Bravo Gonzalez-Blas","year":"2023","journal-title":"Nat. Methods"},{"issue":"3","key":"10.1016\/j.gene.2026.150360_b0030","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1158\/1541-7786.MCR-18-0451","article-title":"Ovarian tumor cell expression of claudin-4 reduces apoptotic response to paclitaxel","volume":"17","author":"Breed","year":"2019","journal-title":"Mol. Cancer Res."},{"issue":"D1","key":"10.1016\/j.gene.2026.150360_b0035","doi-asserted-by":"crossref","first-page":"D1467","DOI":"10.1093\/nar\/gkae1128","article-title":"Open targets platform: facilitating therapeutic hypotheses building in drug discovery","volume":"53","author":"Buniello","year":"2025","journal-title":"Nucleic Acids Res."},{"issue":"10","key":"10.1016\/j.gene.2026.150360_b0040","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/s41588-019-0505-9","article-title":"Landscape of stimulation-responsive chromatin across diverse human immune cells","volume":"51","author":"Calderon","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2026.150360_b0045","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research, N., 2011. Integrated genomic analyses of ovarian carcinoma. Nature 474(7353) 609\u2013615.","DOI":"10.1038\/nature10166"},{"issue":"1","key":"10.1016\/j.gene.2026.150360_b0050","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s12967-024-05134-6","article-title":"CD8(+) T cell-based cancer immunotherapy","volume":"22","author":"Chen","year":"2024","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.gene.2026.150360_b0055","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbae101","article-title":"scMLC: an accurate and robust multiplex community detection method for single-cell multi-omics data","volume":"25","author":"Chen","year":"2024","journal-title":"Brief. Bioinform."},{"issue":"1","key":"10.1016\/j.gene.2026.150360_b0060","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1038\/s41467-024-48397-9","article-title":"FLI1 promotes IFN-gamma-induced kynurenine production to impair anti-tumor immunity","volume":"15","author":"Chen","year":"2024","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.gene.2026.150360_b0065","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1093\/hmg\/ddv101","article-title":"Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci","volume":"24","author":"Coetzee","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"10","key":"10.1016\/j.gene.2026.150360_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114810","article-title":"Integration of genetic and chromatin modification data pinpoints autoimmune-specific remodeling of enhancer landscape in CD4(+) T cells","volume":"43","author":"Daga","year":"2024","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.gene.2026.150360_b0075","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41587-020-00795-2","article-title":"Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes","volume":"39","author":"Gao","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.gene.2026.150360_b0080","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3389\/fimmu.2013.00382","article-title":"Dendritic cell vaccination, immune regulation, and clinical outcomes in ovarian cancer","volume":"4","author":"Goyne","year":"2013","journal-title":"Front. Immunol."},{"issue":"47","key":"10.1016\/j.gene.2026.150360_b0085","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.3748\/wjg.v18.i47.6865","article-title":"Role of nuclear receptor NR4A2 in gastrointestinal inflammation and cancers","volume":"18","author":"Han","year":"2012","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.gene.2026.150360_b0090","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.celrep.2017.02.011","article-title":"BET-bromodomain inhibitors engage the host immune system and regulate expression of the immune checkpoint ligand PD-L1","volume":"18","author":"Hogg","year":"2017","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.gene.2026.150360_b0095","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.gene.2026.150360_b0100","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/1075265","article-title":"CLDN4 as a novel diagnostic and prognostic biomarker and its association with immune infiltrates in ovarian cancer","volume":"2023","author":"Hu","year":"2023","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.gene.2026.150360_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122637","article-title":"The function of the ELF3 gene and its mechanism in cancers","volume":"346","author":"Ju","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.gene.2026.150360_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1514780","article-title":"KLF4: a multifunctional nexus connecting tumor progression and immune regulation","volume":"16","author":"Ju","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.gene.2026.150360_b0115","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1038\/s41467-022-31919-8","article-title":"A multi-omic dissection of super-enhancer driven oncogenic gene expression programs in ovarian cancer","volume":"13","author":"Kelly","year":"2022","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.gene.2026.150360_b0120","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/s41423-018-0004-4","article-title":"When worlds collide: Th17 and Treg cells in cancer and autoimmunity","volume":"15","author":"Knochelmann","year":"2018","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.gene.2026.150360_b0125","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1186\/s12967-025-06745-3","article-title":"Development of a prognostic immune cell-based model for ovarian cancer using multiplex immunofluorescence","volume":"23","author":"Li","year":"2025","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.gene.2026.150360_b0130","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12967-025-06267-y","article-title":"Histidine metabolism drives liver cancer progression via immune microenvironment modulation through metabolic reprogramming","volume":"23","author":"Liu","year":"2025","journal-title":"J. Transl. Med."},{"issue":"18","key":"10.1016\/j.gene.2026.150360_b0135","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1016\/j.cell.2024.06.013","article-title":"Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors","volume":"187","author":"Luo","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.gene.2026.150360_b0140","first-page":"7","article-title":"Spatial proteomics of ovarian cancer precursors delineates early disease changes and drug targets","volume":"22","author":"Makhmut","year":"2026","journal-title":"Mol. Syst. Biol."},{"issue":"2","key":"10.1016\/j.gene.2026.150360_b0145","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.celrep.2019.12.034","article-title":"Mouse Ovarian cancer models recapitulate the human tumor microenvironment and patient response to treatment","volume":"30","author":"Maniati","year":"2020","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.gene.2026.150360_b0150","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41698-024-00640-8","article-title":"Spatial tumor immune microenvironment phenotypes in ovarian cancer","volume":"8","author":"Mateiou","year":"2024","journal-title":"NPJ Precis. Oncol."},{"issue":"10","key":"10.1016\/j.gene.2026.150360_b0155","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.trecan.2024.07.009","article-title":"CD4(+) T cells in antitumor immunity","volume":"10","author":"Montauti","year":"2024","journal-title":"Trends Cancer"},{"issue":"12","key":"10.1016\/j.gene.2026.150360_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126532","article-title":"Ovarian cancer immunotherapy and personalized medicine","volume":"22","author":"Morand","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.gene.2026.150360_b0165","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ajhg.2021.11.020","article-title":"Functional analysis of the 1p34.3 risk locus implicates GNL2 in high-grade serous ovarian cancer","volume":"109","author":"Nakamura","year":"2022","journal-title":"Am. J. Hum. Genet."},{"issue":"12","key":"10.1016\/j.gene.2026.150360_b0170","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1016\/j.immuni.2021.11.015","article-title":"Cytotoxic CD4(+) T cells in cancer: expanding the immune effector toolbox","volume":"54","author":"Oh","year":"2021","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.gene.2026.150360_b0175","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13073-021-00922-x","article-title":"High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification","volume":"13","author":"Olbrecht","year":"2021","journal-title":"Genome Med."},{"issue":"5","key":"10.1016\/j.gene.2026.150360_b0180","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.celrep.2019.09.064","article-title":"Batf pioneers the reorganization of chromatin in developing effector T cells via Ets1-dependent recruitment of Ctcf","volume":"29","author":"Pham","year":"2019","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.gene.2026.150360_b0185","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.cell.2014.11.021","article-title":"A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping","volume":"159","author":"Rao","year":"2014","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.gene.2026.150360_b0190","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.cell.2018.10.022","article-title":"Impact of genetic polymorphisms on human immune cell gene expression","volume":"175","author":"Schmiedel","year":"2018","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.gene.2026.150360_b0195","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41576-019-0128-0","article-title":"Long-range enhancer-promoter contacts in gene expression control","volume":"20","author":"Schoenfelder","year":"2019","journal-title":"Nat. Rev. Genet."},{"issue":"4","key":"10.1016\/j.gene.2026.150360_b0200","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.trecan.2017.03.006","article-title":"Super-enhancer-driven transcriptional dependencies in cancer","volume":"3","author":"Sengupta","year":"2017","journal-title":"Trends Cancer"},{"issue":"9","key":"10.1016\/j.gene.2026.150360_b0205","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1111\/j.1349-7006.2009.01239.x","article-title":"Therapeutic antitumor efficacy of monoclonal antibody against Claudin-4 for pancreatic and ovarian cancers","volume":"100","author":"Suzuki","year":"2009","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.gene.2026.150360_b0210","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s42003-025-08771-9","article-title":"Overcoming platinum-resistant ovarian cancer targeting the activated JAK-STAT pathways via extracellular vesicles","volume":"8","author":"Suzuki","year":"2025","journal-title":"Commun. Biol."},{"issue":"7","key":"10.1016\/j.gene.2026.150360_b0215","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1038\/s41596-020-0336-2","article-title":"A scalable SCENIC workflow for single-cell gene regulatory network analysis","volume":"15","author":"Van de Sande","year":"2020","journal-title":"Nat. Protoc."},{"issue":"7941","key":"10.1016\/j.gene.2026.150360_b0220","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41586-022-05496-1","article-title":"Ovarian cancer mutational processes drive site-specific immune evasion","volume":"612","author":"Vazquez-Garcia","year":"2022","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.gene.2026.150360_b0225","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1016\/j.celrep.2018.05.050","article-title":"Targeting EZH2 reprograms intratumoral regulatory T cells to enhance cancer immunity","volume":"23","author":"Wang","year":"2018","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.gene.2026.150360_b0230","article-title":"ETS transcription factors: multifaceted players from cancer progression to tumor immunity","volume":"1878","author":"Wang","year":"2023","journal-title":"Biochim. Biophys. Acta"},{"issue":"38","key":"10.1016\/j.gene.2026.150360_b0235","doi-asserted-by":"crossref","DOI":"10.4028\/b-XDTcg5","article-title":"Discovery of natural compound alpha-hederin via large-scale screening as a targeted JAK\/STAT3 inhibitor for ovarian cancer therapy","volume":"12","author":"Wang","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"issue":"8","key":"10.1016\/j.gene.2026.150360_b0240","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.tibs.2023.04.005","article-title":"Activation, decommissioning, and dememorization: enhancers in a life cycle","volume":"48","author":"Wu","year":"2023","journal-title":"Trends Biochem. Sci."},{"issue":"16","key":"10.1016\/j.gene.2026.150360_b0245","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1158\/1078-0432.CCR-22-0296","article-title":"Single-cell RNA sequencing reveals the tissue architecture in human high-grade serous ovarian cancer","volume":"28","author":"Xu","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.gene.2026.150360_b0250","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13059-020-01957-w","article-title":"Histone H3K27 acetylation is dispensable for enhancer activity in mouse embryonic stem cells","volume":"21","author":"Zhang","year":"2020","journal-title":"Genome Biol."},{"issue":"12","key":"10.1016\/j.gene.2026.150360_b0255","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jgg.2023.05.003","article-title":"eQTL studies: from bulk tissues to single cells","volume":"50","author":"Zhang","year":"2023","journal-title":"J. Genet. Genomics"},{"key":"10.1016\/j.gene.2026.150360_b0260","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1253238","article-title":"PITX1 plays essential functions in cancer","volume":"13","author":"Zhao","year":"2023","journal-title":"Front. Oncol."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926003707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926003707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:48:24Z","timestamp":1789991304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111926003707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":52,"alternative-id":["S0378111926003707"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2026.150360","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrative multi-omics analysis identifies an enhancer-driven ELF3\u2013CLDN4 regulatory axis that shapes an immunosuppressive microenvironment and predicts prognosis in high-grade serous ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2026.150360","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150360"}}